This protocol outlines the preparation of embryonic mouse retinal explants, which provides an effective technique to analyze neurite outgrowth in central nervous system (CNS) neurons. This validated ex vivo system, which displays limited neuronal death, is highly reproducible and particularly amenable to manipulation. Our previously published studies involving embryonic chick or adult mouse retinal explants were instrumental in the preparation of this protocol; aspects of these previous techniques were combined, adopted and optimized. This protocol thus permits more efficient analysis of neurite growth. Briefly, the retina is dissected from the embryonic mouse eye using precise techniques that take into account the small size of the embryonic eye. The approach applied ensures that the retinal ganglion cell (RGC) layer faces the adhesion substrate on coated cover slips. Neurite growth is clear, well-delineated and readily quantifiable. These retinal explants can therefore be used to examine the neurite growth effects elicited by potential therapeutic agents.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.exer.2016.04.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intravitreal chlorhexidine for sterilizing the vitreous cavity in an animal model of bacterial endophthalmitis.
Cutan Ocul Toxicol
December 2024
Edward Harkness Institute of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University Medical Center, New York, USA.
Article Synopsis
- The study assesses how effective and safe intravitreal chlorhexidine (CHX) is in sterilizing the vitreous cavity for bacterial endophthalmitis.
- In vitro, CHX concentrations above 6.25 µg/mL effectively killed bacteria, and doses below 200 µg/mL did not harm retinal cells.
- Animal testing showed that CHX concentrations of 20-100 µg/mL could sterilize the vitreous without causing harmful effects, suggesting potential for clinical application.*
Messenger RNA (mRNA)-based therapies are a promising approach to medical treatment. Except for infectious diseases, no other disease has mRNA-based therapies available. The eye is an ideal model for mRNA therapeutic development because it requires limited dosing.
View Article and Find Full Text PDFThe Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy.
Invest Ophthalmol Vis Sci
November 2024
Glaucoma Center of Excellence, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Article Synopsis
- The study aimed to explore how topical 2% ripasudil (a Rho kinase inhibitor) protects the nervous system, specifically looking at retinal ganglion cell (RGC) loss in mice exposed to increased intraocular pressure (IOP) and optic nerve damage.
- Results showed that ripasudil significantly reduced RGC axon and soma loss compared to saline-treated controls, indicating its protective effects against nerve damage.
- The findings suggest that ripasudil works by suppressing ROCK signaling pathways in the retina and optic nerve, affecting both RGCs and astrocyte responses to elevated IOP.
Purpose: In October 2023, other cases with early silicone oil opacification within hours after intraocular implantation in the absence of emulsification occurred. While multiple, small series of this phenomenon are now documented during the last decade, the cause was never unmasked. In this study, we analyzed explanted patient samples, unused samples of the affected, and a control batch of the same silicone oil.
View Article and Find Full Text PDFIntravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration.
Int J Mol Sci
October 2024
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL 60637, USA.
Neovascular age-related macular degeneration (nAMD), a leading cause of blindness in older adults, presents a challenging pathophysiology involving choroidal neovascularization (CNV) and retinal degeneration. Current treatments relying on intravitreal (IVT) administration of anti-angiogenic agents are costly and of moderate effectiveness. Metformin, the common anti-diabetic drug, has been associated with decreased odds of developing AMD.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!